TNFα is a key cytokine in endotoxin induced neutrophilic inflammation and theoretically could be a potential target for treatment of CRS, because it inhibits endotoxin-induced neutrophilic inflammation [160]. This evidence concerns the gene TNF and congenital rubella syndrome.